A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

NCT07647510 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis, Generalized

Interventions

DRUG: Claseprubart
DRUG: Placebo
COMBINATION_PRODUCT: Claseprubart
COMBINATION_PRODUCT: Placebo

Sponsor

Dianthus Therapeutics